Axon Enterprise Prices $1 Billion in Zero-Coupon Convertible Notes
Axon Enterprise has priced a $1 billion zero-coupon convertible note offering, raising questions about the true financing cost to the company.
Axon Enterprise has priced a $1 billion offering of zero-coupon convertible notes, a financing structure that carries no stated interest rate but still imposes real costs on the company and its shareholders, according to a report from Yahoo Finance.
Zero-coupon notes do not pay periodic interest to investors. Instead, they are issued at a discount to face value and redeemed at par upon maturity, with the difference representing the investor's return. For the issuer, that gap between the issuance price and the eventual repayment amount constitutes a genuine financing expense, even if no cash interest changes hands during the life of the instrument.
Read more Medical Properties Trust Gets $371M: Debt vs. Revenue Trade-Off →
Convertible notes add another layer of complexity. Investors typically receive the right to convert the notes into company shares at a predetermined price, which can dilute existing shareholders if conversions occur. The conversion feature generally allows issuers to offer lower effective yields than on straight debt, but the potential equity dilution represents an indirect cost that does not appear on a traditional interest expense line.
For Axon, a maker of conducted-energy weapons and law enforcement technology, the offering represents a significant capital markets transaction. Companies often use convertible note proceeds for general corporate purposes, acquisitions, or to fund share repurchase programs designed to offset potential dilution from the conversion feature itself. The true all-in cost to Axon investors and shareholders depends on the discount rate embedded in the notes, the conversion premium set at pricing, and the trajectory of the company's stock price over the notes' term.
Continue reading at Yahoo Finance.